161 related articles for article (PubMed ID: 26067612)
1. Association of anti phosphatidyl ethanolamine antibodies and low complement levels in systemic sclerosis patients--results of a cross-sectional study.
Bălănescu P; Lădaru A; Bălănescu E; Băicuş C; Dan GA
Scand J Clin Lab Invest; 2015 Oct; 75(6):476-81. PubMed ID: 26067612
[TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
Marie I; Jouen F; Hellot MF; Levesque H
Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.
Sobanski V; Lemaire-Olivier A; Giovannelli J; Dauchet L; Simon M; Lopez B; Yelnik C; Lambert M; Hatron PY; Hachulla E; Dubucquoi S; Launay D
Front Immunol; 2018; 9():2457. PubMed ID: 30464761
[No Abstract] [Full Text] [Related]
5. Clinical significance of antiphospholipid antibodies in Indian scleroderma patients.
Gupta R; Thabah MM; Gupta S; Shankar S; Kumar A
Rheumatol Int; 2009 Dec; 30(2):277-9. PubMed ID: 19701755
[TBL] [Abstract][Full Text] [Related]
6. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis--preliminary report.
Sulik A; Kowal-Bielecka O; Domysławska I; Chwiećko J; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():228-31. PubMed ID: 16119673
[TBL] [Abstract][Full Text] [Related]
8. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
10. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibody in localised scleroderma.
Sato S; Fujimoto M; Hasegawa M; Takehara K
Ann Rheum Dis; 2003 Aug; 62(8):771-4. PubMed ID: 12860735
[TBL] [Abstract][Full Text] [Related]
12. [Antibodies against phospholipids in patients with normal pregnancy].
Karagjozova Zh; Tchernev T; Baleva M
Akush Ginekol (Sofiia); 2013; 52(1):3-6. PubMed ID: 23805453
[TBL] [Abstract][Full Text] [Related]
13. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
Hirmerova J; Ulcova-Gallova Z; Seidlerova J; Filipovsky J; Bibkova K; Micanova Z; Mayer O
Clin Appl Thromb Hemost; 2010 Jun; 16(3):318-25. PubMed ID: 19221100
[TBL] [Abstract][Full Text] [Related]
14. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
15. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
17. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
Ofer-Shiber S; Molad Y
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis.
Merashli M; Alves J; Ames PRJ
Semin Arthritis Rheum; 2017 Apr; 46(5):615-624. PubMed ID: 27838012
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss.
Tebo AE; Jaskowski TD; Hill HR; Branch DW
Clin Exp Immunol; 2008 Dec; 154(3):332-8. PubMed ID: 18826497
[TBL] [Abstract][Full Text] [Related]
20. Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
Renaud M; Aupy J; Uring-Lambert B; Chanson JB; Collongues N; Blanc F; De Sèze J
Eur J Neurol; 2014 Jun; 21(6):901-6. PubMed ID: 24698178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]